Provided by Tiger Trade Technology Pte. Ltd.

Trinity Biotech PLC

7.79
-0.2100-2.62%
Post-market: 7.790.00000.00%19:30 EDT
Volume:19.68K
Turnover:157.30K
Market Cap:6.33M
PE:-0.13
High:7.87
Open:7.63
Low:7.30
Close:8.00
52wk High:52.50
52wk Low:7.30
Shares:813.10K
Float Shares:669.10K
Volume Ratio:1.21
T/O Rate:2.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-60.3628
EPS(LYR):-60.3628
ROE:-1913.45%
ROA:-5.72%
PB:-0.09
PE(LYR):-0.13

Loading ...

European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading

MT Newswires Live
·
Apr 07

Trinity Biotech interim CFO Paul Murphy files initial beneficial ownership statement

Reuters
·
Apr 03

Trinity Biotech director Andrew Omidvar files initial beneficial ownership statement

Reuters
·
Apr 03

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Apr 02

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
Mar 31

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Mar 26

Trinity Biotech reports 85% AUC in 750-sample study of enhanced EpiCapture prostate cancer test; commercialization plans advance via New York reference laboratory

Reuters
·
Mar 25

BUZZ-Trinity Biotech rises as prostate cancer test shows strong accuracy

Reuters
·
Mar 23

Trinity Biotech Plc - Plans to Commercialize Epicapture Test Through New York Reference Laboratory

THOMSON REUTERS
·
Mar 23

Trinity Biotech Plc - New Epicapture Test Delivers Clinical Accuracy (Auc) of 85% in Latest Study

THOMSON REUTERS
·
Mar 23

Trinity Biotech Announces Successful Clinical Results for Its Enhanced Epicapture™ Prostate Cancer Test

THOMSON REUTERS
·
Mar 23

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading

MT Newswires Live
·
Mar 19

European Equities Traded in US as ADRs Fall in Wednesday Trading

MT Newswires Live
·
Mar 18

BRIEF-Trinity Biotech Announces Collaboration With University At Buffalo To Commercialize Novel Biomarkers For Sjögren’S Syndrome

Reuters
·
Mar 18

Trinity Biotech Announces Collaboration With University at Buffalo to Commercialize Novel Biomarkers for SjÖGren’s Syndrome

THOMSON REUTERS
·
Mar 18

Trinity Biotech executives to attend ATTD 2026 for CGM+ collaboration talks

Reuters
·
Mar 16